Deliverable Volume

SUN PHARMACEUTICAL INDUSTRIES LTD.

NSE : SUNPHARMABSE : 524715ISIN CODE : INE044A01036Industry : Pharmaceuticals & DrugsHouse : Sun Pharma
BSE1483.80-55.8 (-3.62 %)
PREV CLOSE ( ) 1539.60
OPEN PRICE ( ) 1560.05
BID PRICE (QTY) 1482.80 (27)
OFFER PRICE (QTY) 1483.70 (171)
VOLUME 50422
TODAY'S LOW / HIGH ( )1481.65 1560.70
52 WK LOW / HIGH ( )922.55 1638.7
NSE1487.25-52.85 (-3.43 %)
PREV CLOSE( ) 1540.10
OPEN PRICE ( ) 1562.00
BID PRICE (QTY) 1487.25 (81)
OFFER PRICE (QTY) 1487.35 (4)
VOLUME 4984283
TODAY'S LOW / HIGH( ) 1485.05 1562.45
52 WK LOW / HIGH ( )922.45 1638.85
Exchange
Period From  
Period To  
Date Total Volume Deliverable Volume Deliverable Volume (%)

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.